<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Medicine and Health Sciences : Pharmacology: Antimicrobial Resistance Epidemic of" exact="influenza" post="A(H1N1)pdm09 analyzed by full genome sequences and the first"/>
 <result pre="first case of oseltamivir-resistant strain in Myanmar 2017 Epidemic of" exact="influenza" post="A(H1N1)pdm09 in Myanmar http://orcid.org/0000-0003-3939-4185Kyaw WinSu MonConceptualizationData curationFormal analysisInvestigationMethodologySoftwareValidationVisualizationWriting –"/>
 <result pre="and source are credited.pone.0229601.pdf Abstract A community outbreak of human" exact="influenza" post="A(H1N1)pdm09 virus strains was observed in Myanmar in 2017."/>
 <result pre="investigated the circulation patterns, antigenicity, and drug resistance of 2017" exact="influenza" post="A(H1N1)pdm09 viruses from Myanmar and characterized the full genome"/>
 <result pre="A(H1N1)pdm09 viruses from Myanmar and characterized the full genome of" exact="influenza" post="virus strains in Myanmar from in-patients and out-patients to"/>
 <result pre="A(H1N1)pdm09 viruses in Myanmar were similar to the recommended Japanese" exact="influenza" post="vaccine strain for 2017–2018 seasons (A/Singapore/GP1908/2015) and WHO recommended"/>
 <result pre="Myanmar. This study reported the first detection of an oseltamivir-resistant" exact="influenza" post="virus in Myanmar, highlighting the importance of continuous antiviral"/>
 <result pre="importance of continuous antiviral monitoring and genetic characterization of the" exact="influenza" post="virus in Myanmar. Funding the International Development Strategy Program"/>
 <result pre="in temperate areas of the northern and southern hemispheres; however," exact="influenza" post="outbreaks in tropical areas around the equator may occur"/>
 <result pre="A(H1N1)pdm09 virus, which emerged in 2009 and caused a global" exact="influenza" post="pandemic, is now a seasonal influenza virus that co-circulates"/>
 <result pre="and caused a global influenza pandemic, is now a seasonal" exact="influenza" post="virus that co-circulates with another seasonal influenza (H3N2) and"/>
 <result pre="now a seasonal influenza virus that co-circulates with another seasonal" exact="influenza" post="(H3N2) and influenza B viruses. Worldwide circulation of A(H1N1)pdm09"/>
 <result pre="influenza virus that co-circulates with another seasonal influenza (H3N2) and" exact="influenza" post="B viruses. Worldwide circulation of A(H1N1)pdm09 virus has raised"/>
 <result pre="which has been sharing data with the WHO by sending" exact="influenza" post="isolates twice annually to the WHO collaborating center for"/>
 <result pre="annually to the WHO collaborating center for new vaccine development," exact="influenza" post="genotyping, antiviral susceptibility, monitoring Influenza-like illness (ILI), and Severe"/>
 <result pre="illness (ILI), and Severe Acute Respiratory Infection (SARI) surveillance. However," exact="influenza" post="surveillance efforts in Myanmar are limited. In 2017, the"/>
 <result pre="the support of WHO [5]. In Myanmar, the first pandemic" exact="influenza" post="A(H1N1) 2009 case was detected in June 2009, with"/>
 <result pre="cases. Since then, it has been co-circulating with other seasonal" exact="influenza" post="viruses in the country. Previously, we reported the epidemiology"/>
 <result pre="country. Previously, we reported the epidemiology and genetic characterization of" exact="influenza" post="virus A and B circulating in Myanmar [6, 7]"/>
 <result pre="[6, 7] and characterized the drug-susceptibility of seasonal and pandemic" exact="influenza" post="A(H1N1) viruses in Myanmar in 2008 and 2009 [8]."/>
 <result pre="susceptibility to oseltamivir [8]. In July 2017, severe cases of" exact="influenza" post="A(H1N1)pdm09 were detected in Myanmar, and the MoHS declared"/>
 <result pre="and the MoHS declared a high alert to mitigate the" exact="influenza" post="outbreaks in the country. The overall numbers of severe"/>
 <result pre="influenza outbreaks in the country. The overall numbers of severe" exact="pneumonia" post="cases and fatal cases reached 1198 and 38, respectively"/>
 <result pre="successfully controlled in October 2017 by implementing and strengthening active" exact="influenza" post="surveillance through early and timely detection of cases and"/>
 <result pre="In this study, we investigated the circulation patterns, distribution of" exact="influenza" post="subtypes, antigenic and genetic characterization of influenza A(H1N1)pdm09 virus"/>
 <result pre="patterns, distribution of influenza subtypes, antigenic and genetic characterization of" exact="influenza" post="A(H1N1)pdm09 virus strains and assessed their susceptibility to neuraminidase"/>
 <result pre="(NAIs) in out-patients and in-patients in Myanmar during the 2017" exact="influenza" post="season. Materials and methods Study population Out-patients with influenza-like"/>
 <result pre="diseases, patients with tracheostomy, immunosuppressive status (e.g., HIV infection, chemotherapy)," exact="cystic fibrosis," post="and cancer. Written informed consents were obtained from patients,"/>
 <result pre="(Quick Navi-Flu+RSV, Denka Seiken Co. Ltd., Tokyo, Japan) to screen" exact="influenza" post="virus at the sample collection sites. The other swab"/>
 <result pre="Health, Niigata University, Japan. Virus isolation The positive samples for" exact="influenza" post="A and B, detected by real-time RT-PCR analysis, were"/>
 <result pre="in confluent Madin-Darby canine kidney (MDCK) cells to isolate the" exact="influenza" post="viruses. The cell culture tubes were then incubated at"/>
 <result pre="initial typing and from viral isolate for subtyping/lineage detection of" exact="influenza" post="A or B using QIAamp Viral RNA mini Kit"/>
 <result pre="Institute of Infectious Diseases in Tokyo, Japan [10] to screen" exact="influenza" post="viruses from original clinical specimens for initial typing as"/>
 <result pre="Japan). Complementary DNA was synthesized using uni12 primer for generic" exact="influenza" post="A amplification, as described previously [12]. Cycling probe real-time"/>
 <result pre="or ROX (H275Y) [12]. Neuraminidase inhibitors susceptibility assay The selected" exact="influenza" post="A(H1N1)pdm09 viruses were tested using fluorescence-based inhibition assay (NA"/>
 <result pre="diluted to a final concentration range of 0.005–1250 nM. Each" exact="influenza" post="virus isolate was diluted to a final concentration of"/>
 <result pre="value against one of four drugs is 100-fold elevated for" exact="influenza" post="A [14]. Drug susceptibility assay was performed at Niigata"/>
 <result pre="Nara, and Hokkaido prefectures) in Japan as part of the" exact="influenza" post="investigation conducted by Niigata University during the 2017–2018 season"/>
 <result pre="(GISAID) (S1 and S2 Tables). Reference strains such as the" exact="influenza" post="vaccine strains for the 2017–2018 Japanese vaccine, A/Singapore/GP1908/2015, and"/>
 <result pre="before sample collection. Results Number of samples and detection of" exact="influenza" post="virus types and subtypes From January to December of"/>
 <result pre="tract infections, and tested the samples for the presence of" exact="influenza" post="virus. Rapid test kit assay indicated that a total"/>
 <result pre="a total of 280 samples (45.5%) were positive for the" exact="influenza" post="virus. All 616 nasopharyngeal swab samples were also screened"/>
 <result pre="PCR assay. Influenza A(H1N1)pdm09 viruses represented the majority of circulating" exact="influenza" post="viruses during 2017 (233, 37.8%) (Table 1). 10.1371/journal.pone.0229601.t001Table 1"/>
 <result pre="(Table 1). 10.1371/journal.pone.0229601.t001Table 1 Number of samples and fraction of" exact="influenza" post="virus-positive tests based on real-time PCR analysis in Yangon"/>
 <result pre="on total collected samples Demographic and baseline clinical characteristics of" exact="influenza" post="A(H1N1)pdm09 patients In 2017, the median age of the"/>
 <result pre="influenza A(H1N1)pdm09 patients In 2017, the median age of the" exact="influenza" post="A(H1N1)pdm09 positive out-patients was 3.9 years in Yangon and"/>
 <result pre="All patients enrolled in this study did not receive any" exact="influenza" post="vaccines. Overall the most commonly reported presenting symptoms of"/>
 <result pre="vaccines. Overall the most commonly reported presenting symptoms of the" exact="influenza" post="A(H1N1)pdm09-positive out-patients and in-patients were fever, cough, and rhinorrhea."/>
 <result pre="given symptom. NA—Not Applicable During 2017, the monthly distribution of" exact="influenza" post="virus-positive, as detected by real-time PCR analysis, revealed that"/>
 <result pre="virus-positive, as detected by real-time PCR analysis, revealed that the" exact="influenza" post="season in Myanmar started between June and October. Influenza"/>
 <result pre="B/Yamagata lineage and were observed from August to October, while" exact="influenza" post="B was not detected in Pyinmana (Fig 1). Fig"/>
 <result pre="detected in Pyinmana (Fig 1). Fig 1 Monthly distribution of" exact="influenza" post="virus by region in Myanmar during the 2017 influenza"/>
 <result pre="of influenza virus by region in Myanmar during the 2017" exact="influenza" post="season and the location of sample collection sites. The"/>
 <result pre="A(H1N1)pdm09 was observed in June-July, during the rainy season, and" exact="influenza" post="A(H1N1)pdm09 was the predominant subtype in Myanmar during the"/>
 <result pre="A(H1N1)pdm09 was the predominant subtype in Myanmar during the 2017" exact="influenza" post="season. The map of Myanmar and the green circles"/>
 <result pre="world basemap supplied by ESRI Japan Corporation. Antigenic characterization of" exact="influenza" post="A(H1N1)pdm09 viruses The twelve selected influenza A(H1N1)pdm09 isolates were"/>
 <result pre="Corporation. Antigenic characterization of influenza A(H1N1)pdm09 viruses The twelve selected" exact="influenza" post="A(H1N1)pdm09 isolates were characterized by HI assay to determine"/>
 <result pre="characterized by HI assay to determine the antigenicity of the" exact="influenza" post="virus strains circulating during the outbreak season using post-infection"/>
 <result pre="the vaccine virus, A/Singapore/GP1908/2015, that was used for the Japanese" exact="influenza" post="vaccine strain for the 2017–2018 seasons [23]. A/Singapore/GP1908/2015 is"/>
 <result pre="[23]. A/Singapore/GP1908/2015 is antigenically similar to A/Michigan/45/2005, a WHO selected" exact="influenza" post="vaccine component for the 2017 southern hemisphere [22, 24]."/>
 <result pre="and 4-folds higher than the homologous titer (Table 3). Myanmar" exact="influenza" post="A(H1N1)pdm09 viruses were antigenically similar to the vaccine virus"/>
 <result pre="the vaccine virus A/Singapore/GP1908/2015. 10.1371/journal.pone.0229601.t003Table 3 Antigenic analysis of selected" exact="influenza" post="A(H1N1)pdm09 viruses from Myanmar 2017. Viruses Hemagglutination inhibition (HI)"/>
 <result pre="strain used in Japan for the 2017/18 seasons. Drug resistant" exact="influenza" post="A(H1N1)pdm09 virus Of the 233 influenza A(H1N1)pdm09 viruses from"/>
 <result pre="2017/18 seasons. Drug resistant influenza A(H1N1)pdm09 virus Of the 233" exact="influenza" post="A(H1N1)pdm09 viruses from all the study sites, one isolate"/>
 <result pre="10.1371/journal.pone.0229601.t004Table 4 Frequency of H275Y mutated A(H1N1)pdm09 virus in 2017" exact="influenza" post="season using cycling probe real-time PCR method. Location H275Y"/>
 <result pre="0.4 In vitro fluorescence-based NAI assay performed on the selected" exact="influenza" post="A(H1N1)pdm09 isolates (12 isolates from out-patients and 12 from"/>
 <result pre="the reference virus (Table 5). 10.1371/journal.pone.0229601.t005Table 5 IC50 values of" exact="influenza" post="A(H1N1)pdm09 viruses in Myanmar, 2017. Strain Name Status Drug"/>
 <result pre="laninamivir 0.27nM. Genetic characterization of HA and NA proteins of" exact="influenza" post="A(H1N1)pdm09 viruses The HA and NA genes of influenza"/>
 <result pre="of influenza A(H1N1)pdm09 viruses The HA and NA genes of" exact="influenza" post="A(H1N1)pdm09 viruses in samples selected from 18 out-patients and"/>
 <result pre="of over 90%. Fig 2 HA and NA phylogeny of" exact="influenza" post="A(H1N1) 2009 pandemic isolates in Myanmar in 2017. Trees"/>
 <result pre="separate cluster as HA (Fig 2). Internal gene analysis of" exact="influenza" post="A(H1N1)pdm09 viruses We further characterized the amino acid substitutions"/>
 <result pre="acid substitutions in the remaining six segments of 25 Myanmar" exact="influenza" post="A(H1N1)pdm09 strains, 13 out-patients including a case with NA/H275Y"/>
 <result pre="list of amino acid substitutions found in internal genes of" exact="influenza" post="A(H1N1)pdm09 viruses collected from out-patients and in-patients in Myanmar"/>
 <result pre="be related to drug resistance to amantadine. Discussion A regional" exact="influenza" post="outbreak with the major subtype of A(H1N1)pdm09 occurred in"/>
 <result pre="to October in 2017, and an increased number of severe" exact="pneumonia" post="cases were reported [9]. The viruses involved in this"/>
 <result pre="There were no differences in the genetic characteristics of A(H1N1)pdm09" exact="influenza" post="viruses collected from out-patients and in-patients, including cases with"/>
 <result pre="was detected in our study. In Myanmar, the peak of" exact="influenza" post="virus activity coincides with the rainy season. Myanmar has"/>
 <result pre="and temperature [26]. The study showed that the circulation of" exact="influenza" post="viruses peaked in July, which is consistent with previous"/>
 <result pre="July, which is consistent with previous studies showing that the" exact="influenza" post="season in Myanmar peaked in July or August, during"/>
 <result pre="the national surveillance data reported to the regional and global" exact="influenza" post="surveillance platform (FluNET), which showed that the regional influenza"/>
 <result pre="global influenza surveillance platform (FluNET), which showed that the regional" exact="influenza" post="outbreak started during the rainy season from July (week"/>
 <result pre="season from July (week 29) to September (week 36), and" exact="influenza" post="virus activity peaked in August with 369 flu-positive cases"/>
 <result pre="weeks 31–35 in 2017 [27]. Nationally, an increasing number of" exact="influenza" post="cases was notified in July, and the large number"/>
 <result pre="notified in July, and the large number of samples for" exact="influenza" post="testing became a burden to NIC, which resulted in"/>
 <result pre="a restriction on sample handling in our study sites. Therefore," exact="influenza" post="detection was decreased in August at study sites compared"/>
 <result pre="decreased in August at study sites compared to the national" exact="influenza" post="peak period. Antigenic analysis using the HI test showed"/>
 <result pre="hemisphere vaccine. In this outbreak, Myanmar experienced severe cases of" exact="influenza" post="A/H1N1pdm09 in 2017; however, it turned out that these"/>
 <result pre="vaccine strain. According to the phylogenetic analysis, the 2017 Myanmar" exact="influenza" post="A(H1N1)pdm09 strains belonged to clade 6B.1 and were closely"/>
 <result pre="period. India reported several outbreaks and severe cases caused by" exact="influenza" post="A(H1N1)pdm09 of Clade 6B and 6B.1 during 2015–2017 [16–20,"/>
 <result pre="HA and NA [16]. According to our investigation (unpublished data)," exact="influenza" post="A(H3N2) and B viruses, which were the predominant circulating"/>
 <result pre="of virus strains between in-patients and out-patients but characteristics of" exact="influenza" post="A(H1N1)pdm09 causing viral pneumonia [35–37]. In this study, internal"/>
 <result pre="between in-patients and out-patients but characteristics of influenza A(H1N1)pdm09 causing" exact="viral pneumonia" post="[35–37]. In this study, internal genes of Indian strains"/>
 <result pre="in-patients and out-patients but characteristics of influenza A(H1N1)pdm09 causing viral" exact="pneumonia" post="[35–37]. In this study, internal genes of Indian strains"/>
 <result pre="in the M2 segment that confers resistance to amantadine. Adamantane-resistant" exact="influenza" post="variants have been circulating in the world for decades"/>
 <result pre="mutation in NA that confer resistant to oseltamivir from an" exact="influenza" post="A(H1N1)pdm09 isolate in community samples of Myanmar, which was"/>
 <result pre="its detection rate was low at only 0.5%. In Myanmar," exact="influenza" post="A(H1N1)pdm09 was first detected in 2009 and the oseltamivir-resistant"/>
 <result pre="[8]. Oseltamivir was not previously used for the treatment of" exact="influenza" post="in Myanmar, but at the time of the outbreak"/>
 <result pre="was administered to the admitted patients with severe cases of" exact="influenza" post="infection (S1 File), but the number of prescribed courses"/>
 <result pre="is not available. It was already reported worldwide that oseltamivir-resistant" exact="influenza" post="A(H1N1)pdm09 virus infections were detected in community settings with"/>
 <result pre="oseltamivir and peramivir. Global analysis on the susceptibility of human" exact="influenza" post="viruses to the NAI reported that the most common"/>
 <result pre="data, it highlights the necessity for continuous monitoring of the" exact="influenza" post="virus and close surveillance of antiviral drug resistance in"/>
 <result pre="resistance in Myanmar. There were no known fatal cases of" exact="influenza" post="A(H1N1)pdm09 reported in Myanmar until 2017. Indeed 2 of"/>
 <result pre="and genetic sequencing were death cases. Moreover, detailed characterization of" exact="influenza" post="A(H1N1)pdm09 viruses is very limited [8] and whole-genome sequencing"/>
 <result pre="viruses is very limited [8] and whole-genome sequencing of Myanmar" exact="influenza" post="A(H1N1)pdm09 strains have not been characterized before our study."/>
 <result pre="be published elsewhere. Conclusion In this study, we characterized the" exact="influenza" post="A(H1N1)pdm09 strains that circulated in Myanmar during the 2017"/>
 <result pre="virulence of the virus, which may cause the severity of" exact="influenza" post="among in-patients by comparing with the out-patient strains. Although"/>
 <result pre="Although viral genome features responsible for the differential severity of" exact="influenza" post="between in-patients and out-patients could not be thoroughly elucidated,"/>
 <result pre="be thoroughly elucidated, we present the first-time characterization of Myanmar" exact="influenza" post="viruses by the full genome sequencing. This study demonstrates"/>
 <result pre="Supporting information S1 Table Details of whole genomes of Myanmar" exact="influenza" post="A(H1N1)pdm09 used in this study. All the data are"/>
 <result pre="Click here for additional data file. S2 Table Details of" exact="influenza" post="A(H1N1)pdm09, HA and NA sequences used in the phylogenetic"/>
 <result pre="in PB2, PB1, PA, NP, MP, and NS protein of" exact="influenza" post="A(H1N1)pdm09 viruses collected from out-patients and in-patients in Myanmar"/>
 <result pre="Asoh, Yoshiko Tsuchihashi, Yutaka Shirahige, and Hirotsune Hamabata for collecting" exact="influenza" post="viruses in Japan. We would like to thank Editage"/>
 <result pre="BastienN, BeaudoinC, TylerS, et al.Nationwide molecular surveillance of pandemic H1N1" exact="influenza" post="A virus genomes: Canada, 2009. PLoS One. 2011;6(1):e1608710.1371/journal.pone.001608721249207 5Central"/>
 <result pre="6DapatC, SaitoR, KyawY, NaitoM, HasegawaG, SuzukiY, et al.Epidemiology of human" exact="influenza" post="A and B viruses in Myanmar from 2005 to"/>
 <result pre="DapatC, ShobugawaY, OdagiriT, HibinoA, KondoH, et al.Phylogeographic analysis of human" exact="influenza" post="A and B viruses in Myanmar, 2010–2015. PLoS One."/>
 <result pre="KyawY, MyintYY, OoHN, OoKY, et al.Delayed emergence of oseltamivir-resistant seasonal" exact="influenza" post="A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar."/>
 <result pre="al.Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic" exact="influenza" post="A(H1N1)pdm09 viruses in Myanmar. Influenza Other Respir Viruses. 2013;7(5):766–71."/>
 <result pre="Center-National Institute of Infectious Diseases. Laboratory protocols for detection of" exact="influenza" post="virus. https://www.niid.go.jp/niid/images/lab-manual/Influenza2014.pdf 11World Health Organization. Manual for the laboratory"/>
 <result pre="TamuraT, et al.Identification of oseltamivir resistance among pandemic and seasonal" exact="influenza" post="A (H1N1) viruses by an His275Tyr genotyping assay using"/>
 <result pre="Organization. Meetings of the WHO working group on surveillance of" exact="influenza" post="antiviral susceptibility—Geneva, November 2011 and June 2012. Weekly Epidemiological"/>
 <result pre="HibinoA, YagamiR, DapatC, OdagiriT, et al.Effectiveness of the quadrivalent inactivated" exact="influenza" post="vaccine in Japan during the 2015–2016 season: A test-negative"/>
 <result pre="10.1016/j.jvacx.2019.10001131384733 16NakamuraK, ShirakuraM, FujisakiS, KishidaN, BurkeDF, SmithDJ, et al.Characterization of" exact="influenza" post="A(H1N1)pdm09 viruses isolated from Nepalese and Indian outbreak patients"/>
 <result pre="Viruses. 2017;11(5):399–403. 10.1111/irv.1246928792671 17PandeyS, SahuM, PotdarV, BardeP. Molecular analysis of" exact="influenza" post="A H1N1pdm09 virus circulating in Madhya Pradesh, India in"/>
 <result pre="Eastern India. PLoS One. 2016;11(12):e016846410.1371/journal.pone.016846427997573 20TandelK, SharmaS, DashPK, ParidaM. Oseltamivir-resistant" exact="influenza" post="A(H1N1)pdm09 virus associated with high case fatality, India 2015."/>
 <result pre="report. https://www.crick.ac.uk/sites/default/files/2018-07/crick_nh_vcm_report_feb_2017_v2.pdf 25DongG, PengC, LuoJ, WangC, HanL, WuB, et al.Adamantane-resistant" exact="influenza" post="a viruses in the world (1902–2013): frequency and distribution"/>
 <result pre="System (GISRS). https://www.who.int/influenza/gisrs_laboratory/flunet/en/ 28collab: World Health Organization. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017 southern hemisphere"/>
 <result pre="influenza virus vaccines for use in the 2017 southern hemisphere" exact="influenza" post="seasonWeekly Epidemiological Record. 2016;41(91):469–84. 29collab: World Health Organization. Recommended"/>
 <result pre="Epidemiological Record. 2016;41(91):469–84. 29collab: World Health Organization. Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017–2018 northern hemisphere"/>
 <result pre="influenza virus vaccines for use in the 2017–2018 northern hemisphere" exact="influenza" post="season. Weekly Epidemiological Record. 2017;11(92):117–28. 30European Centre for Disease"/>
 <result pre="NairS, SivadasS, ArunkumarG. Genetic characterization of hemagglutinin (HA) gene of" exact="influenza" post="A viruses circulating in Southwest India during 2017 season."/>
 <result pre="al.The high frequency of non-aspartic acid residues at HA222 in" exact="influenza" post="A(H1N1) 2009 pandemic viruses is associated with mortality during"/>
 <result pre="association between the HA1 mutation D222G in the 2009 pandemic" exact="influenza" post="A(H1N1) virus and severe clinical outcome, Norway 2009–2010. Euro"/>
 <result pre="hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009" exact="influenza" post="virus. J Virol. 2010;84(22):12069–74. 10.1128/JVI.01639-1020826688 35KashJC, TaubenbergerJK. The role"/>
 <result pre="The role of viral, host, and secondary bacterial factors in" exact="influenza" post="pathogenesis. Am J Pathol. 2015;185(6):1528–36. 10.1016/j.ajpath.2014.08.03025747532 36RuuskanenO, LahtiE, JenningsLC,"/>
 <result pre="37MacIntyreCR, ChughtaiAA, BarnesM, RiddaI, SealeH, TomsR, et al.The role of" exact="pneumonia" post="and secondary bacterial infection in fatal and serious outcomes"/>
 <result pre="secondary bacterial infection in fatal and serious outcomes of pandemic" exact="influenza" post="a(H1N1)pdm09. BMC Infect Dis. 2018;18(1):63710.1186/s12879-018-3548-030526505 38World Health Organization. Influenza"/>
 <result pre="et al.Increased detection in Australia and Singapore of a novel" exact="influenza" post="A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due"/>
 <result pre="CalatayudL, BolotinS, et al.Continued emergence and changing epidemiology of oseltamivir-resistant" exact="influenza" post="A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 2011;16(5):pii:"/>
 <result pre="GregoryV, HuangW, et al.Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors, 2015–2016. Antiviral Res. 2017;146:12–20. 10.1016/j.antiviral.2017.08.00428802866"/>
 <result pre="SuntronwongN, ThongmeeT, et al.Evolution of the neuraminidase gene of seasonal" exact="influenza" post="A and B viruses in Thailand between 2010 and"/>
</results>
